Each week we highlight five things affecting the life sciences industry. Here's the latest. CAR-T therapy for lupus gains attention CAR-T cell therapy shows significant potential in treating lupus—as discussed at ACR 2024--with early trials indicating improved patient outcomes and reduced disease ... READ MORE >
biotech
5 things to know in life sciences: Week of September 16, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New Alzheimer’s drug shows promise in early trials In patients with Alzheimer's disease, astrocytes can either help break down harmful amyloid beta plaques or worsen the condition by secreting amyloid beta ... READ MORE >
5 things to know in life sciences: Week of August 12, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biden administration makes significant investment in oncology treatments The Biden administration is providing $150 million to fund new technologies in the oncology space that enhance the safety and precision ... READ MORE >
5 things to know in life sciences: Week of June 3, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biopharma research productivity increases Recent advancements in artificial intelligence are significantly enhancing research and development productivity by streamlining drug discovery processes, leading to ... READ MORE >
5 things to know in life sciences: Week of March 18, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Revolutionizing surgery: Nvidia and Johnson & Johnson's AI collaboration Per CNBC, Nvidia and Johnson & Johnson are collaborating to develop new artificial intelligence applications for surgery, ... READ MORE >
5 things to know in life sciences: Week of Jan. 29, 2024
This week we highlight the beginning of the first round of Inflation Reduction Act drug negotiations, the increasing popularity of co-working spaces in the biotech industry, and the mergers and acquisitions outlook in the area of central nervous system disorders. We also examine a U.S. Food and Drug ... READ MORE >
5 things to know in life sciences: Week of Jan. 15, 2024
This week we highlight potential new medtech regulations in the UK, challenges facing CAR-T therapies and another CRISPR-based gene therapy approval. We also examine the multi-faceted approach being taken by biotech companies seeking funding or potential exits. Additionally, we look at a new device for ... READ MORE >
5 things to know in life sciences: Week of Oct. 2, 2023
This week we explore a significant financing for an artificial intelligence-based biotech company, an investment in medtech by the UK government and a U.S. Food and Drug Administration visit to a major medtech incubator. We also look at a new product using AI to provide information regarding clinical ... READ MORE >
5 things to know in life sciences: Week of Sept. 25, 2023
This week we explore the development of a drug to grow teeth and the start of clinical trials for rabies vaccines. We also look at the labor shortage in biopharma manufacturing and Medicare’s solvency concerns. In addition, we highlight a survey which shows that artificial intelligence is the top area for ... READ MORE >
5 things to know in life sciences: Week of Sept. 11, 2023
This week we explore the approval of updated COVID-19 vaccines, the announcement of two biotech initial public offerings and a special purpose acquisition company transaction. We also look at the development of a new COVID-19 vaccine and decreased U.S. and European investment in Chinese biotech ... READ MORE >